The Dual Role of the Airway Epithelium in Asthma: Active Barrier and Regulator of Inflammation
Cells · 05.09.2023 · 12 (18) · 2208
DOI: 10.3390/cells12182208 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 05.09.2023. Verfasst von Andreas Frey und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Mucosal Immunology and Diagnostics, Research Center Borstel, 23845 Borstel, Germany. Hauptthemen laut MEDLINE: Asthma, Inflammation, Respiratory Mucosa. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 317 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Center for Lung Research.
Abstract (Originalsprache)
Chronic airway inflammation is the cornerstone on which bronchial asthma arises, and in turn, chronic inflammation arises from a complex interplay between environmental factors such as allergens and pathogens and immune cells as well as structural cells constituting the airway mucosa. Airway epithelial cells (AECs) are at the center of these processes. On the one hand, they represent the borderline separating the body from its environment in order to keep inner homeostasis. The airway epithelium forms a multi-tiered, self-cleaning barrier that involves an unstirred, discontinuous mucous layer, the dense and rigid mesh of the glycocalyx, and the cellular layer itself, consisting of multiple, densely interconnected cell types. On the other hand, the airway epithelium represents an immunologically highly active tissue once its barrier has been penetrated: AECs play a pivotal role in releasing protective immunoglobulin A. They express a broad spectrum of pattern recognition receptors, enabling them to react to environmental stressors that overcome the mucosal barrier. By releasing alarmins—proinflammatory and regulatory cytokines—AECs play an active role in the formation, strategic orientation, and control of the subsequent defense reaction. Consequently, the airway epithelium is of vital importance to chronic inflammatory diseases, such as asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Mucosal Immunology and Diagnostics, Research Center Borstel, 23845 Borstel, Germany.
- Airway Research Center North (ARCN), German Center for Lung Research (DZL), 22927 Großhansdorf, Germany.
- Division of Lung Immunology, Research Center Borstel, 23845 Borstel, Germany.
ORCID-Profile: Lars P Lunding, Michael Wegmann
Förderung
- German Center for Lung Research
Zitieren
APA
Frey, A., Lunding, L. P., & Wegmann, M. (2023). The Dual Role of the Airway Epithelium in Asthma: Active Barrier and Regulator of Inflammation. Cells, 12(18), 2208. https://doi.org/10.3390/cells12182208
Vancouver
Frey A, Lunding LP, Wegmann M. The Dual Role of the Airway Epithelium in Asthma: Active Barrier and Regulator of Inflammation. Cells. 2023;12(18):2208. doi:10.3390/cells12182208
BibTeX
@article{Frey2023,
author = {Frey, Andreas and Lunding, Lars P and Wegmann, Michael},
title = {The Dual Role of the Airway Epithelium in Asthma: Active Barrier and Regulator of Inflammation},
journal = {Cells},
year = {2023},
volume = {12},
number = {18},
pages = {2208},
doi = {10.3390/cells12182208}
}
EUVIMED